openheart.bmj2d
Stroke and bleeding risks in Asian and non-Asian patients with atrial fibrillation: further insights into the ‘East Asian Paradox’
The ‘East Asian Paradox’ refers to a unique risk-benefit trade-off observed in Asian patients for thrombosis versus bleeding, ...
openheart.bmj2d
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent ...
openheart.bmj2d
Mechanical circulatory support in cardiogenic shock: translating trial evidence into real-world practice
While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...
openheart.bmj9d
Association of blood pressure and left ventricular mass with subclinical coronary atherosclerosis
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the risk factors associated with ...
openheart.bmj9d
Global, regional and national burdens of cardiovascular disease attributable to secondhand smoke from 1990–2019: an age-period-cohort analysis
Background Over the past three decades, significant disparities in the global burden of cardiovascular disease (CVD) have ...
openheart.bmj9d
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel
Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...